4//SEC Filing
Agger Mette Kirstine 4
Accession 0000950170-25-082541
CIK 0001604950other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:31 PM ET
Size
5.2 KB
Accession
0000950170-25-082541
Insider Transaction Report
Form 4
Agger Mette Kirstine
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-03+30,000→ 30,000 totalExercise: $3.85Exp: 2035-06-03→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This stock option vests in full upon the earlier of (i) June 3, 2026, or (ii) the next annual meeting of the Issuer's stockholders.
Documents
Issuer
scPharmaceuticals Inc.
CIK 0001604950
Entity typeother
Related Parties
1- filerCIK 0001722234
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:31 PM ET
- Size
- 5.2 KB